Eli Lilly and Novo Nordisk overtook Johnson & Johnson last year. In two years, Eli Lilly's market valuation has increased by 270%, to $722 billion.
The Danish laboratory is now worth more than the French luxury giant LVMH. As for Eli Lilly, it has had the luxury of overtaking Tesla, and is now hot on the heels of Berkshire Hathaway, the conglomerate of billionaire Warren Buffett ($881 billion capitalization) The market is excited by the potential of new drugs to fight diabetes and obesity. It is because of this that the market is so enthusiastic about these two companies. The two companies have generated exceptional enthusiasm in the markets over the last two years. They have become the new kings of pharma. They are the new king of the pharma industry. The new king is Eli Lilly and he is the new King of the Pharma Industry. The King of Pharma is the King of The Pharma Industry, the King Of The Pharmaceutical Industry.